Chang, S-W <br/><br/>
Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes.  [electronic resource] 

 -  The pharmacogenomics journal  01 2018 
 - 106-112 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/tpj.2016.67  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Black or African American<br/>Aged<br/>Alleles<br/>Antihypertensive Agents--therapeutic use<br/>Calcium Channel Blockers--therapeutic use<br/>Diabetes Mellitus--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Genome-Wide Association Study--methods<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Meta-Analysis as Topic<br/>Middle Aged<br/>Odds Ratio<br/>Pharmacogenetics--methods<br/>Polymorphism, Single Nucleotide--genetics<br/>Quantitative Trait Loci--genetics